Stock Price
6.00
Daily Change
0.06 1.01%
Monthly
-3.54%
Yearly
26.58%
Q2 Forecast
5.76

Ardelyx reported $5.1M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Amgen USD 3.96B 464M Dec/2025
Ardelyx USD 5.1M 2.02M Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
Sanofi EUR 3.74B 2.23B Sep/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024